CE vs EGO

Celanese Corporation exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating poor financial health. Despite a recent 1-year price recovery, the company is struggling with negative profit margins (-12.21%), a deeply negative ROE (-22.52%), and a high Debt/Equity ratio of 2.89. Revenue and earnings are in sharp decline, with YoY EPS growth collapsing by 88.3%. The disconnect between the bearish deterministic health scores and the 'Buy' analyst consensus suggests a speculative outlook rather than a fundamental one.

EGO presents a compelling value opportunity, trading at $32.07, which is below its Graham Number ($35.08) and significantly below its growth-based intrinsic value ($74.63). While the Piotroski F-Score of 4/9 indicates only stable financial health rather than strength, the company's low Debt/Equity (0.30) and strong liquidity (Current Ratio 1.83) provide a solid safety buffer. Explosive YoY earnings growth (134.8%) and a very low Forward P/E (5.48) suggest significant upside, though this is currently offset by a bearish technical trend and recent earnings misses.